COMPANY
Hyperfine
Since the raise (Oct 16, 2025): 11 of 11 open jobs were first seen after it.
Hiring
| Title | Location (from posting) | Employer posted | First seen |
|---|---|---|---|
| Clinical Support Specialist - West | Remote | Sep 28, 2026 | Oct 9, 2026 |
| Director, People | Guilford, Connecticut | Sep 4, 2026 | Oct 9, 2026 |
| Director, People | Palo Alto, CA - Hybrid | Sep 4, 2026 | Oct 9, 2026 |
| Senior AI Scientist | Palo Alto, CA - Hybrid | Aug 5, 2026 | Oct 9, 2026 |
| Regional Sales Director - New York City (NYC-Based) | New York City, New York | Jul 22, 2026 | Oct 9, 2026 |
Timeline
- Board tracked Radar started tracking this company’s job board (11 open jobs at last check). source ↗
- FDA FDA 510(k) clearance: Swoop® Portable MR Imaging® System — K262622, Aug 19, 2026. Applicant at approval: Hyperfine, Inc. source ↗
- Trial start Not phased (device or behavioral study): Evaluation of Gadolinium Based Contrast Agents for Portable MR Imaging Systems source ↗
- FDA FDA 510(k) clearance: Swoop® Portable MR Imaging® System — K253489, Dec 12, 2025. Applicant at approval: Hyperfine, Inc. source ↗
- Raise Follow-on offering: $17.5M (total, as published), announced Oct 16, 2025. Source: SEC filing. source ↗
- FDA FDA 510(k) clearance: Swoop® Portable MR Imaging® System (V2) — K250236, May 30, 2025. Applicant at approval: Hyperfine, Inc. source ↗
- FDA FDA 510(k) clearance: Swoop® Portable MR Imaging® System — K251276, May 21, 2025. Applicant at approval: Hyperfine, Inc. source ↗
- Raise Follow-on offering — Registered direct: $6M (total, as published), announced Feb 11, 2025. Source: SEC filing. source ↗
Upcoming milestones
- Oct 31, 2026 (ESTIMATED) · Not phased · Evaluation of Gadolinium Based Contrast Agents for Portable MR Imaging Systems · NCT07296263
Open jobs 11
| Title | Location (from posting, not HQ) | Employer posted | First seen | Level |
|---|---|---|---|---|
| Clinical Support Specialist - West | Remote | Sep 28, 2026 | Oct 9, 2026 | Mid |
| Director, People | Guilford, Connecticut | Sep 4, 2026 | Oct 9, 2026 | Senior |
| Director, People | Palo Alto, CA - Hybrid | Sep 4, 2026 | Oct 9, 2026 | Senior |
| Senior AI Scientist | Palo Alto, CA - Hybrid | Aug 5, 2026 | Oct 9, 2026 | Senior |
| Regional Sales Director - New York City (NYC-Based) | New York City, New York | Jul 22, 2026 | Oct 9, 2026 | Senior |
| Software Engineer, Cloud | Palo Alto, CA - Hybrid | Jun 30, 2026 | Oct 9, 2026 | Mid |
| Test Automation Engineer | Palo Alto, CA - Hybrid | Jun 30, 2026 | Oct 9, 2026 | Mid |
| Staff Product Manager | Palo Alto, CA - Hybrid | Apr 3, 2026 | Oct 9, 2026 | Senior |
| Senior Software Engineer, Cloud | Guilford, Connecticut | Dec 19, 2025 | Oct 9, 2026 | Senior |
| Senior AI Scientist | Guilford, Connecticut | Aug 29, 2025 | Oct 9, 2026 | Senior |
| Senior RF & Electromagnetics Engineer - Future Opportunities | Guilford, Connecticut | Aug 18, 2025 | Oct 9, 2026 | Not stated |
Funding
Clinical trials (lead sponsor) 1
| Record | Title | Phase | Status | Start | Primary completion |
|---|---|---|---|---|---|
| NCT07296263 | Evaluation of Gadolinium Based Contrast Agents for Portable MR Imaging Systems | Not phased (device or behavioral study) | Active, not recruiting | Dec 30, 2025 | Oct 31, 2026 (estimated) |
FDA records (last 2 years)
- FDA 510(k) clearance: Swoop® Portable MR Imaging® System — K262622, Aug 19, 2026. Applicant at approval: Hyperfine, Inc. source ↗
- FDA 510(k) clearance: Swoop® Portable MR Imaging® System — K253489, Dec 12, 2025. Applicant at approval: Hyperfine, Inc. source ↗
- FDA 510(k) clearance: Swoop® Portable MR Imaging® System (V2) — K250236, May 30, 2025. Applicant at approval: Hyperfine, Inc. source ↗
- FDA 510(k) clearance: Swoop® Portable MR Imaging® System — K251276, May 21, 2025. Applicant at approval: Hyperfine, Inc. source ↗
Connect
See your connections at Hyperfine on LinkedIn (search by name, results not checked)